+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyperhidrosis Treatment Market by Treatment Type (Injectable Treatments, Medical Devices, Oral Medications), Distribution Channel (E Commerce, OTC, Prescription), Anatomical Site, Condition Type, Treatment Setting - Global Forecast 2025-2030- Product Image
Hyperhidrosis Treatment Market by Treatment Type (Injectable Treatments, Medical Devices, Oral Medications), Distribution Channel (E Commerce, OTC, Prescription), Anatomical Site, Condition Type, Treatment Setting - Global Forecast 2025-2030- Product Image
Sale

Hyperhidrosis Treatment Market by Treatment Type (Injectable Treatments, Medical Devices, Oral Medications), Distribution Channel (E Commerce, OTC, Prescription), Anatomical Site, Condition Type, Treatment Setting - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715634
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hyperhidrosis treatment market is experiencing steady growth, propelled by clinical innovation and expanding patient awareness. As industry leaders respond to shifting patient needs, a broader array of therapies and care models are shaping the way stakeholders address this chronic condition.

Market Snapshot: Hyperhidrosis Treatment Market Growth

The hyperhidrosis treatment market grew from USD 647.88 million in 2024 to USD 694.14 million in 2025, with continued expansion projected at a CAGR of 7.01%, reaching USD 973.01 million by 2030. This positive outlook is driven by rising global incidence, advancements in minimally invasive therapies, and greater emphasis on patient quality of life. Industry players are responding to evolving clinical needs with innovative device-based, pharmacologic, and digital health solutions, encouraging adoption across both established and emerging healthcare systems.

Scope & Segmentation

  • Treatment Types: Injectable treatments with botulinum toxin type A and B; medical devices such as iontophoresis and microwave thermolysis equipment; oral medications including anticholinergics and beta blockers; surgical interventions for refractory cases; topical agents like aluminum chloride hexahydrate and glycopyrronium tosylate.
  • Distribution Channels: E-commerce; over-the-counter via online and retail pharmacies; prescription pathways in dermatology clinics and hospitals.
  • Anatomical Sites: Targeted protocols for face, feet, palms, and underarm sweating.
  • Condition Types: Primary (idiopathic) and secondary (systemic-related) hyperhidrosis.
  • Treatment Settings: General and specialized clinics, home-based management, and hospital care (inpatient and outpatient).
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple key markets), and Asia-Pacific (China, India, Japan, Australia, among others).
  • Key Companies Covered: AbbVie Inc., Bausch Health Companies Inc., Ipsen S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Hologic, Inc., Eli Lilly and Company, Evolus, Inc., Revance Therapeutics, Inc., and Dermira, Inc.

Key Takeaways for Senior Decision-Makers

  • Growing patient and clinician awareness underscores the increasing recognition of hyperhidrosis as a medically significant condition, not just a cosmetic concern.
  • Progress in device and pharmaceutical development reflects stakeholder commitment to more personalized and tolerable therapies, better suiting real-world patient needs.
  • Partnerships between academic, biotech, and device firms are accelerating innovation cycles, shaping the market through clinical research and regulatory engagement.
  • Vertical integration and portfolio diversification by leading brands are allowing comprehensive solutions that improve patient outcomes and competitive positioning.
  • Healthcare providers and payers are collaborating to establish robust health economics evidence, supporting more stable reimbursement frameworks and improved treatment accessibility.

Tariff Impact on Global Supply Chains

Anticipated 2025 tariff measures in the United States are reshaping cost dynamics for hyperhidrosis therapy suppliers. Tariffs on imported device components are increasing expenses for manufacturers, particularly those producing iontophoresis and microwave thermolysis systems. Additional levies on active pharmaceutical ingredients affecting oral therapy producers have prompted organizations to explore mitigation strategies, such as diversifying suppliers and reevaluating distribution contracts. This evolving landscape is influencing how companies manage risk, preserve margins, and secure uninterrupted product access for end users.

Methodology & Data Sources

This report leverages a combined approach, integrating primary research—through extensive interviews with clinicians, device engineers, and payers across major regions—and secondary research using regulatory documents, trial registries, and financial reports. Insights were validated by triangulating data sources, ensuring accuracy and reproducibility across all presented findings.

Why This Report Matters

  • Enables senior leaders to identify practical growth opportunities, anticipate market disruptions, and inform resource allocation in emerging hyperhidrosis therapies.
  • Provides a transparent framework for understanding evolving patient needs, reimbursement landscapes, and technology adoption, supporting better strategic planning.

Conclusion

The hyperhidrosis treatment market is defined by clinical advancement, adaptive business strategies, and policy-driven complexity. Stakeholders that align efforts toward patient-centric outcomes and strategic innovation will be best positioned to navigate the sector’s evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of microwave thermolysis devices for targeted sweat gland ablation in severe hyperhidrosis
5.2. Increasing patient preference for topical anticholinergic formulations with enhanced skin penetration and tolerability
5.3. Expansion of reimbursement coverage by public and private payers for botulinum toxin injections in axillary hyperhidrosis treatment
5.4. Growing integration of digital health platforms and wearable sweat sensors for real time hyperhidrosis symptom monitoring
5.5. Pipeline focus on novel orally administered antimuscarinic agents with improved efficacy and reduced systemic side effects
5.6. Rising investment in teledermatology and virtual care programs to improve access to hyperhidrosis specialist consultations
5.7. Regional market growth driven by increasing awareness and diagnosis rates in Asia Pacific emerging economies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hyperhidrosis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Injectable Treatments
8.2.1. Botulinum Toxin Type A
8.2.2. Botulinum Toxin Type B
8.3. Medical Devices
8.3.1. Iontophoresis Devices
8.3.2. Microwave Thermolysis Devices
8.4. Oral Medications
8.4.1. Anticholinergics
8.4.2. Beta Blockers
8.5. Surgical Treatments
8.6. Topical Agents
8.6.1. Aluminum Chloride Hexahydrate
8.6.2. Glycopyrronium Tosylate
9. Hyperhidrosis Treatment Market, by Distribution Channel
9.1. Introduction
9.2. E Commerce
9.3. OTC
9.3.1. Online Pharmacies
9.3.2. Retail Pharmacies
9.4. Prescription
9.4.1. Dermatology Clinics
9.4.2. Hospitals
10. Hyperhidrosis Treatment Market, by Anatomical Site
10.1. Introduction
10.2. Face
10.3. Feet
10.4. Palms
10.5. Underarm
11. Hyperhidrosis Treatment Market, by Condition Type
11.1. Introduction
11.2. Primary Hyperhidrosis
11.3. Secondary Hyperhidrosis
12. Hyperhidrosis Treatment Market, by Treatment Setting
12.1. Introduction
12.2. Clinic
12.2.1. General Clinics
12.2.2. Specialized Clinics
12.3. Home
12.4. Hospital
12.4.1. Inpatient
12.4.2. Outpatient
13. Americas Hyperhidrosis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hyperhidrosis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hyperhidrosis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Bausch Health Companies Inc.
16.3.3. Ipsen S.A.
16.3.4. Galderma S.A.
16.3.5. Merz Pharma GmbH & Co. KGaA
16.3.6. Hologic, Inc.
16.3.7. Eli Lilly and Company
16.3.8. Evolus, Inc.
16.3.9. Revance Therapeutics, Inc.
16.3.10. Dermira, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HYPERHIDROSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HYPERHIDROSIS TREATMENT MARKET: RESEARCHAI
FIGURE 26. HYPERHIDROSIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 27. HYPERHIDROSIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 28. HYPERHIDROSIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HYPERHIDROSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY IONTOPHORESIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY IONTOPHORESIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MICROWAVE THERMOLYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MICROWAVE THERMOLYSIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ALUMINUM CHLORIDE HEXAHYDRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ALUMINUM CHLORIDE HEXAHYDRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GLYCOPYRRONIUM TOSYLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GLYCOPYRRONIUM TOSYLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FEET, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FEET, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PALMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PALMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY UNDERARM, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY UNDERARM, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRIMARY HYPERHIDROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRIMARY HYPERHIDROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SECONDARY HYPERHIDROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SECONDARY HYPERHIDROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 157. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 162. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 163. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 164. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 165. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 166. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 167. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 170. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 171. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 172. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 173. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 174. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 175. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 177. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 178. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 179. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 180. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 181. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 182. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 188. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 189. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 196. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 197. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 198. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 199. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 204. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 205. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 206. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 207. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 315. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 316. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 317. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2025-2030 (USD MILLION)
TABLE 319. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hyperhidrosis Treatment market report include:
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Ipsen S.A.
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Hologic, Inc.
  • Eli Lilly and Company
  • Evolus, Inc.
  • Revance Therapeutics, Inc.
  • Dermira, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 694.14 Million
Forecasted Market Value ( USD ) by 2030 $ 973.01 Million
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hyperhidrosis Treatment Market Report 2025 - Product Image

Hyperhidrosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Hyperhidrosis Treatment - Global Strategic Business Report - Product Image

Hyperhidrosis Treatment - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Palmar Hyperhidrosis Treatment Global Market Report 2025 - Product Image

Palmar Hyperhidrosis Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Palmar Hyperhidrosis Epidemiology Forecast 2025-2034 - Product Image

Palmar Hyperhidrosis Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Hyperhidrosis - Pipeline Insight, 2025 - Product Image

Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From

About the Hyperhidrosis Drug Market

Hyperhidrosis is a medical condition characterized by excessive sweating. It is a common disorder that affects millions of people worldwide. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of disorders related to hormones and the endocrine system. Hyperhidrosis is a disorder that is often treated by endocrinologists. The hyperhidrosis drug market is a rapidly growing segment of the endocrinology market. It is driven by the increasing prevalence of hyperhidrosis, the availability of new treatments, and the growing awareness of the condition. The market is expected to grow at a steady rate in the coming years due to the increasing demand for effective treatments. Some of the major companies in the hyperhidrosis drug market include GlaxoSmithKline, Merck & Co., Pfizer, Johnson & Johnson, and Novartis. These companies are actively involved in the development and marketing of drugs for the treatment of hyperhidrosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.